![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MAYNE PHARMA: PORTUGAL DRUG BODY OKS GENERIC ELOXATIN
MAYNE PHARMA: PORTUGAL DRUG BODY OKS GENERIC ELOXATIN
In May, the U.K. High Court ruled in favor of Mayne Pharma in a patent infringment lawsuit relating to Eloxatin. The ruling cleared the way for a U.K. launch for Mayne's generic copy subject to regulatory approval. A court in Germany has also ruled that Mayne's process to manufacture the active ingredient used in Eloxatin doesn't infringe the patents held by Sanofi. Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=38316&lang=fra&NewsRubrique=2)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct